ARCA biopharma, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ABIO on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
10170 Church Ranch Way, Suite 100, Westminster, Colorado

There are no Buy or Sell transactions made by insiders since 7/6/2023

ARCA biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Funicular Funds, LP Other*, 10%+ Owner $22.9 M Dec 15, 2022
Funicular Fund, LP Other* $6.45 M May 23, 2022
Christopher David Ozeroff S.V.P., General Counsel $127 K Dec 14, 2021
Robert E. Conway Director, Chairman of the Board $125 K Jan 30, 2024
Thomas A. Keuer Chief Operating Officer $102 K Dec 8, 2022
C. Jeffrey Dekker Chief Financial Officer $100 K Dec 8, 2022
Michael R. Bristow Pres. & Chief Executive Offic, Director $12 K Dec 14, 2021
Daniel J. Mitchell Director $1.53 K Jan 30, 2024
Raymond L. Woosley Director Jan 30, 2024
James P. Flynn Director Jan 30, 2024
Anders D. Hove Director Jan 30, 2024
Jacob Ma-Weaver Director, Other*, 10%+ Owner Jan 30, 2024
Linda Grais Director Jan 30, 2024

Recent Insider Transactions by Companies or Individuals for ARCA biopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership